The compound's compatibility with both cell-based and biochemical assays makes it an effective reference standard and benchmarking tool for evaluating new chemical entities targeting related pathways
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
Testing typically uses urinalysis with polygraph examination in some federations
Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations